Laura Hernández‐Folgado

Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21

Francisco Javier Pavón, Ainhoa Bilbao, Laura Hernández‐Folgado et al. · Neuropharmacology · 2006 · 113 citations

Cannabis Use, Molecular Pharmacology, Psychoactive Drug +8

Discovery of 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1<i>H</i>-1,2,4-triazole, a Novel in Vivo Cannabinoid Antagonist Containing a 1,2,4-Triazole Motif

Nadine Jagerovic, Laura Hernández‐Folgado, Ibón Alkorta et al. · Journal of Medicinal Chemistry · 2004 · 65 citations · Full text

Cannabis Use, Molecular Pharmacology, Medicinal Chemistry +14

Anti‐obesity efficacy of LH‐21, a cannabinoid CB₁ receptor antagonist with poor brain penetration, in diet‐induced obese rats

Mónica Alonso, Antonia Serrano, Margarita Vida et al. · British Journal of Pharmacology · 2011 · 57 citations · Full text

Guanidiniocarbonylpyrrole–Aryl Derivatives: Structure Tuning for Spectrophotometric Recognition of Specific DNA and RNA Sequences and for Antiproliferative Activity

Laura Hernández‐Folgado, Domagoj Baretić, Ivo Piantanida et al. · Chemistry - A European Journal · 2010 · 41 citations · Full text

Molecular Biology, Chemical Biology, Nucleic Acid Biomarkers +20

Chromenopyrazoles: Non‐psychoactive and Selective CB₁ Cannabinoid Agonists with Peripheral Antinociceptive Properties

José Cumella, Laura Hernández‐Folgado, Rocı́o Girón et al. · ChemMedChem · 2012 · 34 citations · Full text